US to invest $160m in cancer partnership

By Rebecca Trager2017-10-17T11:44:00

$C:\Users\traceys\Downloads$

Source: Shutterstock

Funds will be backed up with $55m from 11 companies to advance new cancer treatments that harness the immune system

The US National Institutes of Health (NIH) has launched a partnership with 11 companies to accelerate development of new cancer immunotherapies. The biomedical research agency said this $215 million effort supports the Obama administration’s ‘cancer moonshot’ goal of delivering immunotherapy more quickly to patients.